Company: PACB
Filing Date: 2025-05-12
Form Type: 10-Q
Source: 0001299130-25-000102
Chunk: 169

Company: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Filing Date: 2025-05-12
Form: 10-Q
Item: Part I, Item 1
Chunk 169
---
 value of the liability. A decrease in the discount rates, which include the risk-free rate and estimated subordinated credit spread for CCC credit rating, may result in an increase in the fair value of the liability.Changes in the estimated fair value of the contingent consideration liability for the three months ended March 31, 2025 were as follows:(In thousands)Level 3Beginning balance as of December 31, 2024$18,700 Change in estimated fair value(18,700)Ending balance as of March 31, 2025$— Changes to the fair value are recorded as change in fair value of contingent consideration in the condensed consolidated statement of operations and comprehensive loss.

Q1 Fiscal 2025 Form 10-Q11

Cash, Cash Equivalents, Restricted Cash, and InvestmentsThe following tables summarize our cash, cash equivalents, restricted cash, and investments:As of March 31, 2025(In thousands)AmortizedCost GrossunrealizedgainsGrossunrealizedlossesFairValueCash and cash equivalents$58,507 $1 $(1)$58,507 Investments:Corporate debt securities 38,635 169 (14)38,790 U.S. government & agency securities245,587 283 (57)245,813 Total investments 284,222 452 (71)284,603 Total cash, cash equivalents and investments $342,729 $453 $(72)$343,110 Short-term restricted cash$690 $— $— $690 Long-term restricted cash$1,532 $— $— $1,532 As of December 31, 2024(In thousands)AmortizedCostGrossunrealizedgainsGrossunrealizedlossesFairValueCash and cash equivalents$55,370 $— $— $55,370 Investments:Corporate debt securities46,746 184 (25)46,905 U.S. government & agency securities287,393 418 (155)287,656 Total investments334,139 602 (180)334,561 Total cash, cash equivalents and investments$389,509 $602 $(180)$389,931 Short-term restricted cash$690 $— $— $690 Long-term restricted cash$1,532 $— $— $1,532 The following table